Extraction and Purification of FAHD1 Protein from Swine Kidney and Mouse Liver
February 18th, 2022
5.1K views
This protocol describes how to extract fumarylacetoacetate hydrolase domain-containing protein 1 (FAHD1) from swine kidney and mouse liver. The listed methods may be adapted to other proteins of interest and modified for other tissues.
Overview
This protocol describes the extraction of fumarylacetoacetate hydrolase domain-containing protein 1 (FAHD1) from swine kidney and mouse liver. This method allows for the protein to be extracted in its physiological form, preserving its folding and catalytic activity.
Key Study Components
Area of Science
- Biochemistry
- Protein Purification
- Physiological Protein Extraction
Background
- Purification of recombinant proteins from bacteria is common but can present challenges.
- Extracting proteins from tissues maintains their physiological context.
- This method can be adapted for various proteins and tissues.
- Purified proteins from tissues can aid in developing antibodies and pharmacological inhibitors.
Purpose of Study
- To provide a reliable method for extracting FAHD1 from swine and mouse tissues.
- To demonstrate the advantages of using tissue-derived proteins.
- To facilitate the adaptation of this method for other proteins.
Methods Used
- Extraction of FAHD1 from swine kidney and mouse liver.
- Adaptation of methods for other proteins and tissues.
- Preservation of protein's physiological form during extraction.
- Utilization of extracted proteins for antibody and inhibitor development.
Main Results
- Successful extraction of FAHD1 in its physiological form.
- Demonstrated adaptability of the method for other proteins.
- Highlighted the potential for high-quality antibody development.
- Showed the importance of physiological context in protein extraction.
Conclusions
- The method provides a viable approach for protein extraction from tissues.
- Maintaining physiological conditions is crucial for protein functionality.
- This protocol can enhance research in protein-related studies.
Frequently Asked Questions
What is FAHD1?
FAHD1 is a protein involved in various metabolic processes.
Why extract proteins from tissues?
Extracting proteins from tissues preserves their natural state and functionality.
Can this method be used for other proteins?
Yes, the method can be adapted for various proteins and tissues.
What are the benefits of using tissue-derived proteins?
Tissue-derived proteins maintain physiological relevance, aiding in functional studies.
How does this method support antibody development?
Purified proteins from tissues can lead to the generation of high-quality antibodies.
Is this method applicable to all tissues?
The method can be modified for different tissues, depending on the protein of interest.
Executive Industry Relevance
Extracting proteins from native tissue preserves physiological folding and post-translational modifications critical for functional assays. This approach supports target validation by providing biologically relevant protein forms for mechanistic studies. Purified FAHD1 enables antibody and inhibitor development, reducing reliance on recombinant systems that may lack native conformation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of FAHD1's oxaloacetate decarboxylase activity in mitochondrial context.
- Operational Value: Provides native protein for assessing ligand binding and enzymatic inhibition.
Screening & Assay Development
- Scientific Value: Purified FAHD1 supports development of biochemical assays for compound screening.
- Operational Value: Standardized extraction yields consistent protein for assay reproducibility.
Translational & Preclinical Research
- Scientific Value: Tissue-derived FAHD1 facilitates biomarker studies linking metabolic function to disease models.
- Operational Value: Enables preclinical evaluation of FAHD1-modulating compounds in relevant systems.
Pipeline & Workflow Integration
This method fits early discovery workflows where physiological protein form informs target confidence and assay design.
- Discovery Biology: Supports hypothesis testing via functional validation of mitochondrial enzyme activity.
- Screening: Delivers purified protein for hit identification in enzymatic or binding assays.
- Analytics: Enables quantitative Western blot and activity measurements for hit validation.
- Translational Research: Connects to preclinical studies through tissue-specific protein extraction.
- Enterprise Reuse: Adaptable pipeline for other mitochondrial or metabolic proteins across tissues.
Operational & Enterprise Impact
- Scientific Value: Mechanistic de-risking through native-state protein functional characterization.
- Operational Value: Reproducible extraction and purification using standard chromatography equipment.
- Strategic Value: Informs go/no-go decisions by confirming target engagement in physiological context.
- Portfolio Impact: Enables prioritization of FAHD1 modulators based on target-specific activity.
Implementation Considerations
- Requires expertise in protein extraction, chromatography, and Western blot analysis.
- Dependent on FPLC systems, centrifugation equipment, and spectrophotometric activity assays.
- Needs standardization across labs for consistent ammonium sulfate precipitation and buffer conditions.
- Adaptation to other tissues requires optimization of lysis and precipitation parameters.
- Limited by protein solubility and susceptibility to precipitation at high ammonium sulfate concentrations.
Biopharma FAQs
Why does ammonium sulfate precipitation matter for protein extraction yield?
Ammonium sulfate precipitation concentrates FAHD1 from tissue lysates, enabling downstream chromatography steps. The protocol shows that optimizing saturation levels improves recovery while minimizing precipitation artifacts. This step is critical for achieving detectable yields in low-abundance mitochondrial proteins.
How does ionic exchange chromatography contribute to FAHD1 purification?
Anionic exchange chromatography separates FAHD1 from contaminating proteins based on charge differences under low-to-high salt gradients. Fractions containing FAHD1 are identified by Western blot, pooled, and concentrated for further purification. This step reduces complexity before size-exclusion chromatography, improving final purity.
What quantitative measurements enable assessment of FAHD1 purity and activity?
Western blot analysis provides semi-quantitative assessment of FAHD1 presence and purity across purification steps. Enzymatic activity assays measure oxaloacetate decarboxylase function, correlating activity with purity levels. These outputs help determine optimal conditions for functional protein recovery.
Why are replication requirements important for cross-functional collaboration in protein extraction?
Reproducible extraction across swine kidney and mouse liver tissues validates the method's adaptability to different sources. Consistent yields and purity levels enable shared protocols between discovery and preclinical teams. This reliability supports technology transfer and assay standardization in multi-site projects.
What statistical analysis capabilities are required before implementing this extraction method?
Basic statistical comparison of yield and purity across replicates ensures method robustness before implementation. Comparing FAHD1 signal intensity in Western blots across fractions helps identify true positives. These analyses support decision-making on process optimization and scalability for antibody or inhibitor development programs.
Chapters in this video
0:04
Introduction
0:55
Preparation of Buffer, Tissue Sample, and Solution
2:15
Total Protein Extraction
3:42
SDS-PAGE and Western Blot Analysis
4:39
Ammonium Sulfate Precipitation
6:28
Ionic Exchange Chromatography with FPLC
8:14
Protein Extraction Using Defined Sub-Protocols for Ammonium Sulfate-Precipitation and FPLC
9:32
Results: Extraction and Purification of FAHD1 Protein from Swine Kidney and Mouse Liver
11:24
Conclusion
